[Central hemodynamic function and the metabolic electrolyte ratio of patients with hypertension and hereditary

Terapevticheskii Arkhiv
|January 1, 1985
PubMed

Insights

Hypertension with hereditary aggravation presents with higher blood pressure, requiring more medication. This severity may stem from increased blood vessel sensitivity to angiotensin, impacting treatment efficacy.

Area of Science:

  • Cardiology
  • Nephrology
  • Endocrinology

Background:

  • Arterial hypertension (AH) is a significant cardiovascular risk factor.
  • Hereditary factors can influence AH development and severity.
  • Understanding these influences is crucial for effective management.

Purpose of the Study:

  • To investigate peculiarities in the course of arterial hypertension (AH) in patients with and without hereditary aggravation.
  • To evaluate the efficacy of hypotensive therapy in these patient groups.
  • To explore potential underlying mechanisms contributing to AH severity in hereditary cases.

Main Methods:

  • Comparative analysis of 69 hypertensive patients with hereditary aggravation and 92 without.
  • Radionuclide assessment of sodium, potassium, and water content and distribution.
  • Measurement of central and renal hemodynamics, plasma renin activity, aldosterone, and urinary catecholamines.
  • Assessment of natriuretic response to furosemide (Lasix).

Main Results:

  • Hypertension with hereditary aggravation showed higher systolic and diastolic blood pressure, particularly in men.
  • These patients required higher doses of antihypertensive medications (hemiton, beta-blockers) for normalization.
  • A higher sodium/renin index suggested increased vascular sensitivity to angiotensin in hereditary cases.
  • Both groups exhibited an excessive natriuretic response to furosemide compared to normotensive individuals.

Conclusions:

  • Hereditary aggravation is associated with a more severe course of arterial hypertension.
  • Increased vascular sensitivity to angiotensin may contribute to this severity.
  • While electrolyte distribution was similar, altered renin-angiotensin system activity plays a role.
  • Further research into genetic predispositions for hypertension is warranted.

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...